ECM
MRK icon

ETrade Capital Management’s Merck MRK Stock Holding History

ETrade Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$11.7M Buy
147,226
+8,529
+6% +$668K 0.22% 49
2020
Q2 		$10.2M Buy
138,697
+16,780
+14% +$1.26M 0.21% 52
2020
Q1 		$8.95M Buy
121,917
+20,670
+20% +$1.62M 0.23% 50
2019
Q4 		$8.79M Buy
101,247
+684
+0.7% +$56.2K 0.2% 59
2019
Q3 		$8.08M Buy
100,563
+41,925
+71% +$3.36M 0.2% 57
2019
Q2 		$4.69M Sell
58,638
-2,271
-4% -$174K 0.13% 89
2019
Q1 		$4.83M Buy
60,909
+1,119
+2% +$83.7K 0.14% 75
2018
Q4 		$4.36M Sell
59,790
-5,570
-9% -$393K 0.14% 73
2018
Q3 		$4.42M Buy
65,360
+639
+1% +$40.7K 0.13% 91
2018
Q2 		$3.75M Sell
64,721
-39,859
-38% -$2.25M 0.12% 95
2018
Q1 		$5.44M Buy
104,580
+7,759
+8% +$419K 0.18% 59
2017
Q4 		$5.2M Sell
96,821
-8
-0% -$444 0.17% 64
2017
Q3 		$5.92M Sell
96,829
-11,775
-11% -$714K 0.21% 40
2017
Q2 		$6.64M Buy
108,604
+3,499
+3% +$213K 0.26% 32
2017
Q1 		$6.37M Buy
105,105
+3,441
+3% +$209K 0.26% 34
2016
Q4 		$5.71M Sell
101,664
-19,236
-16% -$1.13M 0.26% 34
2016
Q3 		$7.2M Buy
120,900
+22,471
+23% +$1.31M 0.35% 26
2016
Q2 		$5.41M Buy
98,429
+27,849
+39% +$1.48M 0.29% 31
2016
Q1 		$3.56M Buy
70,580
+10,052
+17% +$492K 0.2% 50
2015
Q4 		$3.05M Buy
60,528
+7,443
+14% +$375K 0.18% 58
2015
Q3 		$2.5M Buy
53,085
+3,590
+7% +$191K 0.15% 70
2015
Q2 		$2.69M Buy
49,495
+3,977
+9% +$223K 0.16% 68
2015
Q1 		$2.5M Buy
45,518
+3,905
+9% +$221K 0.15% 84
2014
Q4 		$2.25M Buy
41,613
+4,635
+13% +$258K 0.14% 90
2014
Q3 		$2.09M Buy
36,978
+2,958
+9% +$166K 0.14% 86
2014
Q2 		$1.88M Buy
34,020
+3,938
+13% +$215K 0.12% 120
2014
Q1 		$1.63M Buy
30,082
+1,832
+6% +$94.9K 0.12% 118
2013
Q4 		$1.35M Sell
28,250
-14,979
-35% -$685K 0.11% 138
2013
Q3 		$1.96M Buy
43,229
+8,485
+24% +$387K 0.18% 50
2013
Q2 		$1.54M Buy
+34,744
New +$1.55M 0.16% 49

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ETrade Capital Management's MRK Position: Q3 2020 in Review

ETrade Capital Management increased its Merck (MRK) stake by 6.1% in Q3 2020, buying an estimated $668K and bringing the position to 147,226 shares worth $11.7M. The position accounts for 0.22% of the portfolio, ranked #49.

ETrade Capital Management first reported a position in MRK in Q2 2013 and has held it in 30 quarters since. 2,559 funds tracked by Wall St. Rank hold MRK as of Q3 2020.

  • ETrade Capital Management held 147,226 shares of Merck worth $11.7M as of Q3 2020.
  • ETrade Capital Management bought 8,529 Merck shares in Q3 2020, an estimated $668K.
  • Merck made up 0.22% of ETrade Capital Management's portfolio in Q3 2020, its #49 holding.
  • ETrade Capital Management first reported a position in Merck in Q2 2013 and has held it in 30 quarters since.
  • 2,559 funds tracked by Wall St. Rank held Merck as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.